Cardiac Myosins

"Cardiac Myosins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Myosin type II isoforms found in cardiac muscle.

Descriptor ID	D024722
MeSH Number(s)	D05.750.078.730.475.475.124 D08.811.277.040.025.193.750.750.124 D12.776.210.500.600.470.249 D12.776.220.525.475.475.124
Concept/Terms	Cardiac Myosins Cardiac Myosins Cardiac Myosin Myosin, Cardiac Myosins, Cardiac Cardiac Muscle Myosins Muscle Myosins, Cardiac Myosins, Cardiac Muscle

Below are MeSH descriptors whose meaning is more general than "Cardiac Myosins".

Chemicals and Drugs [D]
Macromolecular Substances [D05]
Polymers [D05.750]
Biopolymers [D05.750.078]
Microfilament Proteins [D05.750.078.730]
Myosins [D05.750.078.730.475]
Myosin Type II [D05.750.078.730.475.475]
Cardiac Myosins [D05.750.078.730.475.475.124]
Enzymes and Coenzymes [D08]
Enzymes [D08.811]
Hydrolases [D08.811.277]
Acid Anhydride Hydrolases [D08.811.277.040]
Adenosine Triphosphatases [D08.811.277.040.025]
Molecular Motor Proteins [D08.811.277.040.025.193]
Myosins [D08.811.277.040.025.193.750]
Myosin Type II [D08.811.277.040.025.193.750.750]
Cardiac Myosins [D08.811.277.040.025.193.750.750.124]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Contractile Proteins [D12.776.210]
Muscle Proteins [D12.776.210.500]
Myosins [D12.776.210.500.600]
Myosin Type II [D12.776.210.500.600.470]
Cardiac Myosins [D12.776.210.500.600.470.249]
Cytoskeletal Proteins [D12.776.220]
Microfilament Proteins [D12.776.220.525]
Myosins [D12.776.220.525.475]
Myosin Type II [D12.776.220.525.475.475]
Cardiac Myosins [D12.776.220.525.475.475.124]

Below are MeSH descriptors whose meaning is related to "Cardiac Myosins".

Below are MeSH descriptors whose meaning is more specific than "Cardiac Myosins".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cardiac Myosins" by people in this website by year, and whether "Cardiac Myosins" was a major or minor topic of these publications.

Bar chart showing 8 publications over 7 distinct years, with a maximum of 2 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	0	1
2005	1	0	1
2011	1	0	1
2013	0	1	1
2021	1	1	2
2022	1	0	1
2023	1	0	1

Below are the most recent publications written about "Cardiac Myosins" by people in Profiles.

Clippinger Schulte SR, Scott B, Barrick SK, Stump WT, Blackwell T, Greenberg MJ. Single-molecule mechanics and kinetics of cardiac myosin interacting with regulated thin filaments. Biophys J. 2023 06 20; 122(12):2544-2555.

View in: PubMed
Lee LA, Barrick SK, Meller A, Walklate J, Lotthammer JM, Tay JW, Stump WT, Bowman G, Geeves MA, Greenberg MJ, Leinwand LA. Functional divergence of the sarcomeric myosin, MYH7b, supports species-specific biological roles. J Biol Chem. 2023 01; 299(1):102657.

View in: PubMed
Hegde SM, Lester SJ, Solomon SD, Michels M, Elliott PM, Nagueh SF, Choudhury L, Zemanek D, Zwas DR, Jacoby D, Wang A, Ho CY, Li W, Sehnert AJ, Olivotto I, Abraham TP. Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2021 12 21; 78(25):2518-2532.

View in: PubMed
Barrick SK, Greenberg MJ. Cardiac myosin contraction and mechanotransduction in health and disease. J Biol Chem. 2021 11; 297(5):101297.

View in: PubMed
Wilson AL, Schrecengost RS, Guerrero MS, Thomas KS, Bouton AH. Breast cancer antiestrogen resistance 3 (BCAR3) promotes cell motility by regulating actin cytoskeletal and adhesion remodeling in invasive breast cancer cells. PLoS One. 2013; 8(6):e65678.

View in: PubMed
Cleland JG, Teerlink JR, Senior R, Nifontov EM, Mc Murray JJ, Lang CC, Tsyrlin VA, Greenberg BH, Mayet J, Francis DP, Shaburishvili T, Monaghan M, Saltzberg M, Neyses L, Wasserman SM, Lee JH, Saikali KG, Clarke CP, Goldman JH, Wolff AA, Malik FI. The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. Lancet. 2011 Aug 20; 378(9792):676-83.

View in: PubMed
Tanaka M, Zwierzchoniewska M, Mokhtari GK, Terry RD, Balsam LB, Robbins RC, Fedoseyeva EV. Progression of alloresponse and tissue-specific immunity during graft coronary artery disease. Am J Transplant. 2005 Jun; 5(6):1286-96.

View in: PubMed
Swoap SJ, Hunter RB, Stevenson EJ, Felton HM, Kansagra NV, Lang JM, Esser KA, Kandarian SC. The calcineurin-NFAT pathway and muscle fiber-type gene expression. Am J Physiol Cell Physiol. 2000 Oct; 279(4):C915-24.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement